Skip to main content
PLOS One logoLink to PLOS One
. 2021 Mar 24;16(3):e0249380. doi: 10.1371/journal.pone.0249380

Correction: Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1)

The PLOS ONE Staff
PMCID: PMC7990200  PMID: 33760884

Notice of republication

This article was republished on October 5, 2020, to include a Publisher’s Note. The Publisher’s Note was added to clarify that the article is a pre-registered research article and to provide information about the assessment process administered by Children’s Tumor Foundation (CTF) and PLOS ONE. Please download the article again to view the correct version. The originally published, uncorrected article and the republished, corrected article are provided here for reference.

Supporting information

S1 File. Originally published, uncorrected article.

(PDF)

S2 File. Republished corrected article.

(PDF)

Reference

  • 1.Vasiljevski ER, Houweling PJ, Rupasinghe T, Kaur T, Summers MA, Roessner U, et al. (2020) Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1). PLoS ONE 15(8): e0237097. 10.1371/journal.pone.0237097 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 File. Originally published, uncorrected article.

(PDF)

S2 File. Republished corrected article.

(PDF)


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES